Investigations on biomarker search in patients with bronchial carcinoma under antibody (checkpoint blockade) therapy
- Conditions
- C34.9Bronchus or lung, unspecified
- Registration Number
- DRKS00022872
- Lead Sponsor
- Krankenhaus Martha-Maria Halle-Dölau
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients must be able to give consent themselves
- signed consent form
- histologically confirmed SCLC with indication for palliative immunochemotherapy
Exclusion Criteria
- histologically confirmed NSCLC
- previous immunotherapies
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression-free survival<br>- Determination by CT scans after 4th cycle and then every 3 months
- Secondary Outcome Measures
Name Time Method Overall survival<br>- Provision for regular inquiries to the family doctor or the clinical cancer register